This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Daniel George, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mCRPC Treatment
          Charles Ryan, MD
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Neal Shore, MD, FACS
        • A Patient Journey
          Alicia Morgans, MD, MPH
          Charles J. Ryan, MD
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
  • Transformative Evidence
    • mCRPC
      • CARD Trial
      • PROfound Study
    • mHSPC
      • ENZAMET Trial
    • nmCRPC
      • PROSPER Trial
    • Advanced Prostate Cancer
      • HERO Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Videos
    • Conference Coverage and Experts Group
      • Interviews with Experts at Conferences
        • ASCO 2019
        • ASCO 2020
        • ASCO GU 2020
        • ESMO 2018
        • ESMO 2020
      • Exclusive Collaborations
        • APCCC 2019
        • LUGPA Annual Meeting 2018
        • LUGPA Annual Meeting 2019
        • PCF 2018
        • PCF 2019
        • SNMMI Curriculum
      • UroToday Exclusives
        • A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
        • Book Club
        • Hot Topic QuickTakes
        • Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
        • COVID-19 and Genitourinary Cancers Videos
        • Large Urology Group Practice Association (LUGPA)
        • Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
    • Urologic Oncology
      • Bladder Cancer
        • Bladder Cancer
        • Bladder Cancer Expert Debates
        • Advanced Bladder Cancer
        • Non-Muscle Invasive Bladder Cancer
      • Kidney Cancer
        • Advanced Kidney Cancer
        • Renal Cancer
      • Prostate Cancer
        • Advances in Nuclear Medicine, PET, and Theranostics
        • Advanced Prostate Cancer
        • Cardiovascular Disease in Men with Prostate Cancer
        • CRPC with Bone Metastases
        • The Expert Voice
        • Imaging: Prostate Cancer
        • Localized Prostate Cancer
        • mCRPC
        • mHSPC
        • Molecular Diagnostics
        • Navigating Cancer
        • nmCRPC
        • The Patient Voice
        • Precision Medicine in Prostate Cancer
        • Prostate Cancer
      • Upper Tract Urothelial Tumors
        • Upper Tract Urothelial Carcinoma
    • Pelvic Health & Reconstruction
      • Bladder Health
      • Indwelling Catheters
      • Intermittent Catheters
      • Nocturia & Lower Urinary Tract Conditions
    • Endourology
      • Endourology Today
      • Endourology
  • Journals
    • Everyday Urology - Oncology Insights
      Everyday Urology - Oncology Insights
      • From the Editor
      • Current Issue
      • Previous Issues
    • Prostate Cancer and Prostatic Diseases
      Prostate Cancer and Prostatic Diseases
      • From the Editor
      • Current Article
      • Previous Articles
  • Clinical Trials
    • Clinical Trials
      • Search Clinical Trials
    • From the Editor
      • Current Letter
      • Previous Letters
  • Conference Coverage
    • Advanced Prostate Cancer Consensus Conference (APCCC)
      • 2019 APCCC Meeting
    • American Society of Clinical Oncology (ASCO)
      • 2020 Virtual Education Program
      • 2020 Annual Meeting
      • 2020 ASCO GU Symposium
      • 2019 Annual Meeting
      • 2019 ASCO GU Symposium
    • American Urological Association (AUA)
      • 2020 Annual Meeting
      • 2019 Annual Meeting
    • ANZUP Mini Annual Scientific Meeting (ASM)
      • 2020 Virtual Annual Meeting
    • Bladder Cancer Advocacy Network (BCAN)
      • 2020 Think Tank Virtual Program
      • 2019 Think Tank
    • Canadian Urological Association (CUA)
      • 2019 CUOS Summit
    • Clinical Conference
      • 2019 American College of Surgeons
    • EMUC
      • 2020 Annual Meeting
    • European Association of Urology (EAU)
      • 2020 Annual Congress
      • 2019 Annual Congress
      • ESOU 2019
    • Enhanced Recovery After Surgery (ERAS)
      • 2019 ERAS Annual Congress
    • European Society for Medical Oncology (ESMO)
      • 2020 Virtual Congress
      • 2019 Annual Congress
    • Global Society of Rare GU Tumors
      • 2020 Meeting
    • International Bladder Cancer Network (IBCN)
      • 2020 Annual Virtual Meeting
      • 2019 Meeting
    • Prostate Cancer Academy
      • 2020 Annual Meeting
    • Société Internationale d'Urologie (SIU)
      • 2020 Annual Congress
      • 2019 Annual Congress
    • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
      • 2019 Therapeutics Conference
    • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
      • 2020 Congress
      • 2019 Congress
    • Society of Urologic Oncology (SUO)
      • 2020 Annual Meeting
      • 2020 SUO - AUA Summer Webcast
      • 2019 Annual Meeting
    • Targeted Alpha Therapy (TAT)
      • 2019 Symposium
    • World Congress of Endourology and SWL (WCE)
      • 2019 Annual Meeting
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Bladder Cancer
      • CRPC w/ Bone Metastases
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Testicular Cancer
      • Upper Tract Tumors
      • Investigative Urology
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
      • Urologic Catheters
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
    • COVID-19 and Genitourinary Cancers
      • COVID-19 and Genitourinary Cancers
  • Calendar
  1. UroToday Home
  2. Conference Highlights

ASCO 2019 Annual Meeting

  • Prostate Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Testicular Cancer
  • Press Releases

ASCO 2019 Annual Meeting

ASCO 2019 Prostate Cancer

  • ASCO 2019: A Multicentric Phase II Randomized Trial of Docetaxel plus Enzalutamide versus Docetaxel as First-line Chemotherapy for Patients with Metastatic Castration-resistant Prostate Cancer: CHEIRON Study
  • ASCO 2019: Updated Approaches to Treatment Sequencing in the Era of M0 CRPC Approvals
  • ASCO 2019: Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy in Men with Clinically Localized, High-Risk Prostate Cancer - CALGB 90203 (Alliance)
  • ASCO 2019: Clinical and Safety Outcomes of TALAPRO-2: A Two-part Phase III Study of Talazoparib in Combination with Enzalutamide in Metastatic Castration-resistant Prostate Cancer
  • ASCO 2019: Predictive Biomarkers in Prostate Cancer
View all (83 articles)

ASCO 2019 Bladder Cancer

  • ASCO 2019: Vofatamab in Combination with Pembrolizumab in WT Metastatic Urothelial Carcinoma: FIERCE-22
  • ASCO 2019: Targeted Therapeutics and Patient Selection in Advanced Urothelial Carcinoma
  • ASCO 2019: Clinical Outcomes According to PD-L1 Status and Age in the Prospective International SAUL Study of Atezolizumab for Locally Advanced or Metastatic Urothelial Carcinoma or Non-UC of the Urinary Tract
  • ASCO 2019: Pembrolizumab for Patients with High-Risk Non–Muscle Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guérin: Updated Follow-Up from KEYNOTE-057
  • ASCO 2019: Comprehensive Genomic Profiling of Upper-Tract and Bladder Urothelial Carcinoma Reveals Opportunities for Therapeutic and Biomarker Development
View all (37 articles)

ASCO 2019 Kidney Cancer

  • ASCO 2019: IMmotion151 Subgroup Analysis: Atezolizumab + Bevacizumab versus Sunitinib in Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Histology
  • ASCO 2019: CheckMate 214 Post-Hoc Analyses of Nivolumab plus Ipilimumab or Sunitinib in IMDC Intermediate/Poor-Risk Patients with Previously Untreated Advanced Renal Cell Carcinoma with Sarcomatoid Features
  • ASCO 2019: Efficacy of Immune Checkpoint Inhibitors and Genomic Characterization of Sarcomatoid and/or Rhabdoid Metastatic Renal Cell Carcinoma
  • ASCO 2019: Patient-Reported Outcomes in IMmotion150: Atezolizumab alone or with Bevacizumab versus Sunitinib in First-Line Metastatic Renal Cell Carcinoma
  • ASCO 2019: Sarcomatoid RCC: Defining a New Treatment Paradigm?
View all (29 articles)

ASCO 2019 Press Releases

  • Janssen Seeks to Expand Use of ERLEADA® (apalutamide) in the Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer
  • Astellas and Seattle Genetics Announce Antibody-Drug Conjugate Enfortumab Vedotin Produced Tumor Response Rate of 44 Percent in Patients with Most Common Type of Advanced Urothelial (Bladder) Cancer
  • ASCO 2019: TITAN: Apalutamide Meets Dual Primary Endpoints, Shows Good Tolerability in Metastatic Hormone Sensitive Prostate Cancer
  • ASCO Announces Top Studies to Be Presented at 2019 Annual Meeting
  • Myriad Genetics to Present Multiple Studies at the 2019 American Society of Clinical Oncology Annual Meeting
View all (6 articles)

ASCO 2019 Testicular Cancer

  • ASCO 2019: Biomarkers of Outcomes in a Randomized Phase II trial of first-line paclitaxel, ifosfamide, and Cisplatin versus Bleomycin, Etoposide, and Cisplatin for Intermediate- and Poor-Risk Germ Cell Tumors
View all (1 article)
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2021 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free